{"ANU": {"name": "Yada Kanjanapan", "link": "https://researchers.anu.edu.au/researchers/kanjanapan-y", "colleges": "College of Health & Medicine", "email": "Yada.Kanjanapan@anu.edu.au", "phone": "", "expertise": [], "interest": [], "biography": "", "project": [], "publication": []}, "Microsoft-Academic": [{"title": "novel patterns of response under immunotherapy", "year": 2019, "source": "annals of oncology", "authors": [{"name": "edith borcoman", "affiliation": "curie institute"}, {"name": "yada kanjanapan"}, {"name": "stephane champiat", "affiliation": "institut gustave roussy"}, {"name": "shumei kato", "affiliation": "university of california san diego"}, {"name": "vincent servois", "affiliation": "curie institute"}, {"name": "razelle kurzrock", "affiliation": "university of california san diego"}, {"name": "sanjay goel", "affiliation": "albert einstein college of medicine"}, {"name": "philippe l bedard"}, {"name": "c le tourneau", "affiliation": "curie institute"}, {"name": "c le tourneau", "affiliation": "french institute of health and medical research"}], "id": 41454044}, {"title": "hyperprogressive disease in early phase immunotherapy trials clinical predictors and association with immune related toxicities", "year": 2019, "source": "cancer", "authors": [{"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "daphne day", "affiliation": "princess margaret cancer centre"}, {"name": "lisa wang", "affiliation": "princess margaret cancer centre"}, {"name": "hamad alsawaihey", "affiliation": "princess margaret cancer centre"}, {"name": "engy abbas", "affiliation": "princess margaret cancer centre"}, {"name": "amirali namini", "affiliation": "princess margaret cancer centre"}, {"name": "lillian l siu", "affiliation": "princess margaret cancer centre"}, {"name": "aaron r hansen", "affiliation": "princess margaret cancer centre"}, {"name": "a abdul razak", "affiliation": "princess margaret cancer centre"}, {"name": "anna spreafico", "affiliation": "princess margaret cancer centre"}, {"name": "natasha b leighl", "affiliation": "princess margaret cancer centre"}, {"name": "anthony m joshua", "affiliation": "princess margaret cancer centre"}, {"name": "marcus o butler", "affiliation": "princess margaret cancer centre"}, {"name": "david hogg", "affiliation": "princess margaret cancer centre"}, {"name": "mary anne chappell", "affiliation": "princess margaret cancer centre"}, {"name": "ludmilla soultani", "affiliation": "princess margaret cancer centre"}, {"name": "kayla chow", "affiliation": "princess margaret cancer centre"}, {"name": "samantha boujos", "affiliation": "princess margaret cancer centre"}, {"name": "philippe l bedard", "affiliation": "princess margaret cancer centre"}], "id": 126033908}, {"title": "seamless designs current practice and considerations for early phase drug development in oncology", "year": 2019, "source": "journal of the national cancer institute", "authors": [{"name": "brian p hobbs", "affiliation": "cleveland clinic"}, {"name": "pedro c barata", "affiliation": "tulane university"}, {"name": "pedro c barata", "affiliation": "cleveland clinic"}, {"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "channing j paller", "affiliation": "johns hopkins university"}, {"name": "jane perlmutter"}, {"name": "gregory r pond", "affiliation": "mcmaster university"}, {"name": "tatiana m prowell", "affiliation": "johns hopkins university"}, {"name": "tatiana m prowell", "affiliation": "food and drug administration"}, {"name": "eric h rubin", "affiliation": "merck co"}, {"name": "lesley seymour", "affiliation": "queen s university"}, {"name": "nolan a wages", "affiliation": "university of virginia"}, {"name": "timothy a yap", "affiliation": "university of texas md anderson cancer center"}, {"name": "david feltquate", "affiliation": "bristol myers squibb"}, {"name": "elizabeth garrettmayer", "affiliation": "american society of clinical oncology"}, {"name": "william grossman", "affiliation": "genentech"}, {"name": "david s hong", "affiliation": "university of texas md anderson cancer center"}, {"name": "s percy ivy"}, {"name": "lillian l siu", "affiliation": "princess margaret cancer centre"}, {"name": "steven a reeves"}, {"name": "gary l rosner", "affiliation": "johns hopkins university"}], "id": 98010888}, {"title": "considerations for cancer immunotherapy during the covid 19 pandemic", "year": 2020, "source": "the medical journal of australia", "authors": [{"name": "yada kanjanapan", "affiliation": "australian national university"}, {"name": "yada kanjanapan", "affiliation": "canberra hospital"}, {"name": "desmond yip", "affiliation": "australian national university"}, {"name": "desmond yip", "affiliation": "canberra hospital"}], "id": 13978405}, {"title": "delayed immune related adverse events in assessment for dose limiting toxicity in early phase immunotherapy trials", "year": 2019, "source": "european journal of cancer", "authors": [{"name": "yada kanjanapan", "affiliation": "university of toronto"}, {"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "daphne day", "affiliation": "university of toronto"}, {"name": "daphne day", "affiliation": "princess margaret cancer centre"}, {"name": "marcus o butler", "affiliation": "university of toronto"}, {"name": "marcus o butler", "affiliation": "princess margaret cancer centre"}, {"name": "lisa wang", "affiliation": "princess margaret cancer centre"}, {"name": "anthony m joshua", "affiliation": "university of toronto"}, {"name": "anthony m joshua", "affiliation": "princess margaret cancer centre"}, {"name": "david hogg", "affiliation": "university of toronto"}, {"name": "david hogg", "affiliation": "princess margaret cancer centre"}, {"name": "natasha b leighl", "affiliation": "university of toronto"}, {"name": "natasha b leighl", "affiliation": "princess margaret cancer centre"}, {"name": "a abdul razak", "affiliation": "university of toronto"}, {"name": "a abdul razak", "affiliation": "princess margaret cancer centre"}, {"name": "aaron r hansen", "affiliation": "university of toronto"}, {"name": "aaron r hansen", "affiliation": "princess margaret cancer centre"}, {"name": "s boujos", "affiliation": "princess margaret cancer centre"}, {"name": "maryanne chappell", "affiliation": "princess margaret cancer centre"}, {"name": "k chow", "affiliation": "princess margaret cancer centre"}, {"name": "b sherwin", "affiliation": "princess margaret cancer centre"}, {"name": "leeanne stayner", "affiliation": "princess margaret cancer centre"}, {"name": "l soultani", "affiliation": "princess margaret cancer centre"}, {"name": "aaron zambrana", "affiliation": "princess margaret cancer centre"}, {"name": "lillian l siu", "affiliation": "university of toronto"}, {"name": "lillian l siu", "affiliation": "princess margaret cancer centre"}, {"name": "philippe l bedard", "affiliation": "princess margaret cancer centre"}, {"name": "anna spreafico", "affiliation": "university of toronto"}, {"name": "anna spreafico", "affiliation": "princess margaret cancer centre"}], "id": 16731738}, {"title": "denosumab induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure", "year": 2013, "source": "internal medicine journal", "authors": [{"name": "n farinola", "affiliation": "royal adelaide hospital"}, {"name": "yada kanjanapan", "affiliation": "royal adelaide hospital"}], "id": 60716783}, {"title": "phase ii clinical and molecular trial of oral enmd 2076 in clear cell ovarian cancer ccoc a study of the princess margaret phase ii consortium", "year": 2017, "source": "journal of clinical oncology", "authors": [{"name": "stephanie lheureux", "affiliation": "princess margaret cancer centre"}, {"name": "julia v burnier", "affiliation": "princess margaret cancer centre"}, {"name": "qian tan", "affiliation": "princess margaret cancer centre"}, {"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "blaise a clarke", "affiliation": "university health network"}, {"name": "anna v tinker", "affiliation": "bc cancer agency"}, {"name": "prafull ghatage", "affiliation": "tom baker cancer centre"}, {"name": "neesha c dhani", "affiliation": "princess margaret cancer centre"}, {"name": "marcus o butler", "affiliation": "princess margaret cancer centre"}, {"name": "stephen welch"}, {"name": "johanne i weberpals"}, {"name": "david shao peng tan", "affiliation": "national university of singapore"}, {"name": "kelly brooks", "affiliation": "princess margaret cancer centre"}, {"name": "janelle ramsahai", "affiliation": "princess margaret cancer centre"}, {"name": "lisa wang", "affiliation": "princess margaret cancer centre"}, {"name": "patricia shaw", "affiliation": "university health network"}, {"name": "mingsound tsao", "affiliation": "university of toronto"}, {"name": "swati garg", "affiliation": "university health network"}, {"name": "tracy l stockley", "affiliation": "university health network"}, {"name": "amit m oza", "affiliation": "princess margaret cancer centre"}], "id": 15137598}, {"title": "development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib", "year": 2015, "source": "european journal of cancer", "authors": [{"name": "chee khoon lee", "affiliation": "national health and medical research council"}, {"name": "david goldstein", "affiliation": "university of new south wales"}, {"name": "emma gibbs", "affiliation": "national health and medical research council"}, {"name": "heikki joensuu", "affiliation": "helsinki university central hospital"}, {"name": "john zalcberg", "affiliation": "monash university"}, {"name": "jaap verweij", "affiliation": "erasmus university rotterdam"}, {"name": "paolo g casali"}, {"name": "robert g maki", "affiliation": "icahn school of medicine at mount sinai"}, {"name": "angela cioffi", "affiliation": "icahn school of medicine at mount sinai"}, {"name": "grant a mcarthur", "affiliation": "peter maccallum cancer centre"}, {"name": "sarah j lord", "affiliation": "national health and medical research council"}, {"name": "desmond yip", "affiliation": "australian national university"}, {"name": "desmond yip", "affiliation": "canberra hospital"}, {"name": "yada kanjanapan", "affiliation": "canberra hospital"}, {"name": "piotr rutkowski"}], "id": 16731738}, {"title": "survival in early phase immuno oncology trials development and validation of a prognostic index", "year": 2019, "source": "jnci cancer spectrum", "authors": [{"name": "daphne day", "affiliation": "university of toronto"}, {"name": "daphne day", "affiliation": "princess margaret cancer centre"}, {"name": "christina guo", "affiliation": "peter maccallum cancer centre"}, {"name": "yada kanjanapan", "affiliation": "university of toronto"}, {"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "ben tran", "affiliation": "peter maccallum cancer centre"}, {"name": "anna spreafico", "affiliation": "university of toronto"}, {"name": "anna spreafico", "affiliation": "princess margaret cancer centre"}, {"name": "anthony m joshua", "affiliation": "university of toronto"}, {"name": "anthony m joshua", "affiliation": "princess margaret cancer centre"}, {"name": "lisa wang", "affiliation": "princess margaret cancer centre"}, {"name": "albiruni r a razak", "affiliation": "university of toronto"}, {"name": "albiruni r a razak", "affiliation": "princess margaret cancer centre"}, {"name": "natasha b leighl", "affiliation": "university of toronto"}, {"name": "natasha b leighl", "affiliation": "princess margaret cancer centre"}, {"name": "aaron r hansen", "affiliation": "university of toronto"}, {"name": "aaron r hansen", "affiliation": "princess margaret cancer centre"}, {"name": "marcus o butler", "affiliation": "university of toronto"}, {"name": "marcus o butler", "affiliation": "princess margaret cancer centre"}, {"name": "lillian l siu", "affiliation": "university of toronto"}, {"name": "lillian l siu", "affiliation": "princess margaret cancer centre"}, {"name": "jayesh desai", "affiliation": "peter maccallum cancer centre"}, {"name": "philippe l bedard", "affiliation": "university of toronto"}, {"name": "philippe l bedard", "affiliation": "princess margaret cancer centre"}], "id": 2735282665}, {"title": "phase ii open label randomized multi centre study of neoadjuvant olaparib in patients pts with platinum sensitive ps relapsed high grade serous ovarian cancer oc the neo trial", "year": 2017, "source": "journal of clinical oncology", "authors": [{"name": "yada kanjanapan", "affiliation": "princess margaret cancer centre"}, {"name": "stephanie lheureux", "affiliation": "princess margaret cancer centre"}, {"name": "taymaa may", "affiliation": "princess margaret cancer centre"}, {"name": "michelle k wilson", "affiliation": "princess margaret cancer centre"}, {"name": "marcus q bernardini"}, {"name": "patricia shaw", "affiliation": "university health network"}, {"name": "ignace vergote", "affiliation": "katholieke universiteit leuven"}, {"name": "james d brenton", "affiliation": "university of cambridge"}, {"name": "diane provencher", "affiliation": "universite de montreal"}, {"name": "iain a mcneish", "affiliation": "university of glasgow"}, {"name": "prafull ghatage", "affiliation": "tom baker cancer centre"}, {"name": "jonathan a ledermann", "affiliation": "university college london"}, {"name": "nicoletta colombo", "affiliation": "university of milano bicocca"}, {"name": "charlie gourley", "affiliation": "university of edinburgh"}, {"name": "johanne i weberpals", "affiliation": "ottawa hospital"}, {"name": "janelle ramsahai", "affiliation": "princess margaret cancer centre"}, {"name": "nicole ricker"}, {"name": "sarah accardi", "affiliation": "princess margaret cancer centre"}, {"name": "lisa wang", "affiliation": "princess margaret cancer centre"}, {"name": "amit m oza", "affiliation": "princess margaret cancer centre"}], "id": 15137598}], "ANDS-Grants": []}